据卫生部文告,迄今为止,本地已有11万3千人接种第一剂冠病19疫苗,超过50人完成第二剂接种。

卫生部称,与卫生科学局密切关注辉瑞疫苗的安全性。截至1月27日,卫生科学局共接到432例接种疫苗后起不良反应的通报,大多是注射处肿痛、发烧、头疼、晕眩等症状,或是红疹等过敏反应。当局声称,这些不良反应逾其他疫苗出现的反应相似,一般在数日就会消退。

还有三名年龄为20、30岁的人士,接种后出现严重过敏,包括喉咙紧缩、气喘、嘴唇红肿和红疹。他们有过敏性鼻炎,以及曾对贝类海鲜过敏。由于不曾出现严重过敏反应才获准接种疫苗。

但当局称,严重过敏及早发现或治疗能受控制。三人目前已康复,并在一天观察或治疗后出院。

本地疫苗严重过敏的发病率,为每10万剂疫苗中有2.7例。

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

NKF terminated CEO Edmund Kwok due to “personal indiscretion”?

The National Kidney Foundation (NKF) announced in a press release the Chief…

Budget 2020: Enhanced MOE Financial Assistance Scheme for students

The Ministry of Education’s (MOE) Financial Assistance Scheme will be enhanced by…

15 countries sign RECP except India which wanted “movement of professionals”

The Regional Comprehensive Economic Partnership (RCEP) was signed by 15 countries yesterday…

Singapore schools to implement one day of home-based learning a week

The Ministry of Education (MOE) has announced that schools will implement one…